Ibandronic acid 50mg oral (off-label use)

Amber-G

Brand Name(s):

Indication: Cancer – breast (Post-menopausal women)

Rationale:

Considered:Sep-16

Review Date:Aug-22

Comments:
NICE TA464
Bisphosphonates for treating osteoporosis
Aug 2017
…………………………
NICE CG164 Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer
…………………………………
Off Label Use. Initiated by hospital specialist. Drug Safety Update
Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal
Full details can be found at: https://www.gov.uk/drug-safety-update/bisphosphonates-very-rare-reports-of-osteonecrosis-of-the-external-auditory-canal
Dec 2015